JPRN-C000000250已完成未知
An Open-label controlled Trial to Assess the Efficacy of Bisphosphonate in the Treatment of Coronary Artery Calcification in Nondialyzed Patients with Diabetic Nephropathy. - Effect of Bisphosphonate on Coronary Artery Calcification in Diabetic Nephropathy
Department of Nephrology, Osaka University School of Medicine0 个研究点目标入组 50 人开始时间: 2006年2月17日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 ot applicable(—)
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients with atrial fibrillation, those who are contraindicated for beta-blockers, pregnant patients, or patients planning pregnancy are excluded.
研究者
相似试验
招募中
不适用
An open-label uncontrolled trial of the efficacy and safety of a hug for promotion of relaxation in pediatric patients with severe motor and intellectual disabilities.JPRN-UMIN000025855ational Hospital Organization Shizuoka Institute of Epilepsy and Neurological Disorders20
已完成
2 期
Ayurvedic management of Acute Coughing and Throat IrritatioCTRI/2020/01/022659Multani Pharmaceuticals Ltd46
尚未招募
2 期
An Clinical Study of Evecare Forte Liquid in PCOS (Polycystic Ovarian Syndrome)CTRI/2017/12/011004The Himalaya Drug Company
已完成
2 期
An uncontrolled open-label study on the efficacy and safety of sirolimus for epileptic seizures associated with focal cortical dysplasia type-IIfocal cortical dysplasia (type-II)JPRN-UMIN000033504Hokkaido University Hospital Nishi-Niigata Chuo National Hospital National Center Hospital, NCNP Shizuoka Institute of Epilepsy and Neurological Disorders Okayama University Hospital16
Unknown
2 期
Clinical evaluation for the efficacy of Muliv strong syrup in the management of Non- Alcoholic Fatty Liver disease (NAFLD).CTRI/2019/12/022578Multani Pharmaceuticals Ltd
